GlassScriptPhysician profile
Nicole Cavignaro
NPI 1508527748
$2,882.63
in general payments reported to CMS, 2019-2025
18 companies · $1,071 in 2025
The $1,071 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,812 · 2025: $1,071.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,698 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,697.65 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $519.23 | 2024-2025 | |
| Janssen Biotech, INC. | $482.38 | 2024-2025 | Tremfya |
| Abbvie INC. | $477.00 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $436.05 | 2024-2025 | Dupixent, Libtayo |
| Ucb, INC. | $382.54 | 2024 | Bimzelx |
| Organon LLC | $106.22 | 2025 | Vtama |
| Pfizer INC. | $70.84 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $65.57 | 2024-2025 | |
| Incyte Corporation | $59.35 | 2024 | Opzelura |
| Galderma Laboratories, L.P. | $54.86 | 2024-2025 | Nemluvio |
| Amgen INC. | $43.18 | 2024-2025 | Otezla, Otezla |
| Lilly USA, LLC | $40.13 | 2024 | Taltz, Ebglyss, Olumiant |
| Organogenesis INC. | $37.99 | 2024 | |
| Dermavant Sciences, INC. | $35.96 | 2024 | Vtama |
| Almirall LLC | $19.96 | 2025 | Klisyri |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.41 | 2024 | Cabtreo, Jublia |
| Verrica Pharmaceuticals INC. | $17.78 | 2024 | Ycanth |
| Arcutis Biotherapeutics, INC. | $15.18 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Cavignaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.